EANM position on the in-house preparation of radiopharmaceuticals

被引：15

作者：

Hendrikse, Harry ^{[1
]}

Kiss, Oliver ^{[2
]}

Kunikowska, Jolanta ^{[3
]}

Wadsak, Wolfgang ^{[4
]}

Decristoforo, Clemens ^{[5
]}

Patt, Marianne ^{[6
]}

机构：

[1] Vrije Univ Amsterdam Med Ctr, Dept Clin Pharmacol & Pharm, Dept Radiol & Nucl Med, Amsterdam, Netherlands

[2] Helmholtz Zentrum Dresden Rossendorf, Dept Radiopharmaceut Prod, Inst Radiopharmaceut Canc Res, Dresden, Germany

[3] Med Univ Warsaw, Nucl Med Dept, Warsaw, Poland

[4] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Div Nucl Med, AKH Wien, Waehringer Guertel 18-20, A-1090 Vienna, Austria

[5] Med Univ Innsbruck, Dept Nucl Med, Innsbruck, Austria

[6] Univ Leipzig, Dept Nucl Med, Leipzig, Germany

来源：

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2022年 / 49卷 / 04期

关键词：

EUROPEAN REGULATIONS; GUIDANCE;

D O I：

10.1007/s00259-022-05694-z

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

The EANM herewith clearly expresses its commitment and support to the non-commercial in-house preparation of radiopharmaceuticals for direct use in accordance with European and national regulations.

引用

页码：1095 / 1098

页数：4

共 11 条

[1] Guidance on current good radiopharmacy practice for the small-scale preparation of radiopharmaceuticals using automated modules: a European perspective [J].

Aerts, Joel ;

Ballinger, James R. ;

Behe, Martin ;

Decristoforo, Clemens ;

Elsinga, Philip H. ;

Faivre-Chauvet, Alain ;

Mindt, Thomas L. ;

Peitl, Petra Kolenc ;

Todde, Sergio C. ;

Koziorowski, Jacek .

JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2014, 57 (10) :615-620

[2]

[Anonymous], EUROPEAN PHARMACOPOE, P807

[3]

Council of Europe European Pharmacopoeia Commission European Directorate for the Quality of Medicines Healthcare, 2020, EUROPEAN PHARMACOPOE

[4]

Daue, 2017, EUDRALEX

[5] Emerging Radionuclides in a Regulatory Framework for Medicinal Products - How Do They Fit? [J].

Decristoforo, Clemens ;

Neels, Oliver ;

Patt, Marianne .

FRONTIERS IN MEDICINE, 2021, 8

[6] European regulations for the introduction of novel radiopharmaceuticals in the clinical setting [J].

Decristoforo, Clemens ;

Penuelas, Ivan ;

Patt, Marianne ;

Todde, Sergio .

QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 61 (02) :135-144

[7] Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals [J].

Gillings, Nic ;

Hjelstuen, Olaug ;

Ballinger, Jim ;

Behe, Martin ;

Decristoforo, Clemens ;

Elsinga, Philip ;

Ferrari, Valentina ;

Peitl, Petra Kolenc ;

Koziorowski, Jacek ;

Laverman, Peter ;

Mindt, Thomas L. ;

Neels, Oliver ;

Ocak, Meltem ;

Patt, Marianne ;

Todde, Sergio .

EJNMMI RADIOPHARMACY AND CHEMISTRY, 2021, 6 (01)

[8] EANM guideline on the validation of analytical methods for radiopharmaceuticals [J].

Gillings, Nic ;

Todde, Sergio ;

Behe, Martin ;

Decristoforo, Clemens ;

Elsinga, Philip ;

Ferrari, Valentina ;

Hjelstuen, Olaug ;

Peitl, Petra Kolenc ;

Koziorowski, Jacek ;

Laverman, Peter ;

Mindt, Thomas L. ;

Ocak, Meltem ;

Patt, Marianne .

EJNMMI RADIOPHARMACY AND CHEMISTRY, 2020, 5 (01)

[9] Untangling the web of European regulations for the preparation of unlicensed radiopharmaceuticals: a concise overview and practical guidance for a risk-based approach [J].

Lange, Rogier ;

ter Heine, Rob ;

Decristoforo, Clemens ;

Penuelas, Ivan ;

Elsinga, Philip H. ;

van der Westerlaken, Monique M. L. ;

Hendrikse, N. Harry .

NUCLEAR MEDICINE COMMUNICATIONS, 2015, 36 (05) :414-422

[10] The new Regulation on clinical trials in relation to radiopharmaceuticals: when and how will it be implemented? [J].

Penuelas, Ivan ;

Vugts, Danielle J. ;

Decristoforo, Clemens ;

Elsinga, Philip H. .

EJNMMI RADIOPHARMACY AND CHEMISTRY, 2019, 4 (01)

← 1 2 →